Cytokinetics reported $-9467000 in EBITDA for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -33.14M 79.36M
Acorda Therapeutics ACOR:US $ -6.2M 1.23M
Amgen AMGN:US $ 3004M 337M
Arca Biopharma ABIO:US $ -5.68M 1.58M
Bayer BAYN:GR € 4762M 490M
Biogen BIIB:US $ 1075.7M 401M
Brainstorm Cell Therapeutics BCLI:US $ -7.52M 2.12M
Bristol Myers Squibb BMY:US $ 5780M 8M
Capricor Therapeutics CAPR:US $ -5.71M 0.23M
Cytokinetics CYTK:US $ -9.47M 67.05M
Eisai 4523:JP Y 17237M 28829M
Eli Lilly And LLY:US $ 1999.4M 1006.2M
Exelixis EXEL:US $ 88.48M 0.75M
Genocea Biosciences GNCA:US $ -15.37M 2.37M
Geron GERN:US $ -27.9M 0.71M
Halozyme Therapeutics HALO:US $ 46.61M 29.84M
Intra Cellular Therapies ITCI:US $ -87.75M 15.26M
Novartis NOVN:VX SF 4660M 108M
Pfizer PFE:US $ 12921M 1739M
Regeneron Pharmaceuticals REGN:US $ 1381.3M 20.4M